| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 03/05/2009 | US20090062777 Administration apparatus for medical use |
| 03/05/2009 | US20090062720 Transdermal Methods and Systems for the Delivery of Corticosteroid Compounds |
| 03/05/2009 | US20090062382 External preparation for improving coital function |
| 03/05/2009 | US20090062362 Veterinary Formulation for Administration of a Water-Insoluble Drug to a Target Animal Through a Water Distribution System |
| 03/05/2009 | US20090062354 Method of increasing the extent of absorption of tizanidine |
| 03/05/2009 | US20090062254 Acute Treatment of Headache with Phenothiazine Antipsychotics |
| 03/05/2009 | US20090062249 An intraocular, biodegradable drug delivery system comprising anecortave acetate and a biodegradable glycolic acid-lactic acid copolymer effective in releasing the immunosuppressant into the eye over a period of > 3 weeks; sustained release from a single pellet or a single extruded filament |
| 03/05/2009 | US20090062205 Reconstitution Medium For Protein and Peptide Formulations |
| 03/05/2009 | US20090062201 Integrin binding motif containing peptides and methods of treating skeletal diseases |
| 03/05/2009 | US20090061682 Coaxial connector having detachable locking sleeve |
| 03/05/2009 | US20090061506 Method for precipitating mono and multiple layers of organophosphoric and organophosphonic acids and the salts thereof in addition to use thereof |
| 03/05/2009 | US20090061152 Methods for fabricating isolated micro- and nano- structures using soft or imprint lithography |
| 03/05/2009 | US20090061071 Porous medical articles for therapeutic agent delivery |
| 03/05/2009 | US20090061048 Delivery and controlled release of encapsulated lipophilic nutrients |
| 03/05/2009 | US20090061011 Compositions and methods for delivery of poorly soluble drugs |
| 03/05/2009 | US20090061010 Cancer cell targeting using nanoparticles |
| 03/05/2009 | US20090061009 Composition and Method of Treatment of Bacterial Infections |
| 03/05/2009 | US20090061008 Fiber/granule complex for treatment of the gi tract |
| 03/05/2009 | US20090061007 Pharmaceutical preparation |
| 03/05/2009 | US20090061006 Layered Nanoparticles for Sustained Release of Small Molecules |
| 03/05/2009 | US20090061005 Paliperidone Polymorphs |
| 03/05/2009 | US20090061004 Leave-In Hair Styling Product with Particles for Improving Hair Volume |
| 03/05/2009 | US20090061003 Carriers for drug delivery |
| 03/05/2009 | US20090061002 Calcium phospate based delivery of growth and differentiation factors to compromised bone |
| 03/05/2009 | US20090061001 Sunscreen aerosol spray |
| 03/05/2009 | US20090061000 Pharmaceutical formulation use 030 |
| 03/05/2009 | US20090060999 Protein formulation |
| 03/05/2009 | US20090060998 Lipid-based dispersions useful for drug delivery |
| 03/05/2009 | US20090060997 Process for producing a pharmaceutical preparation for therapeutic treatment of endometriosis containing a combination of a gestagen and (6s)-5-methyltetrahydrofolate |
| 03/05/2009 | US20090060996 Formulations of Clopidogrel Bisulphate |
| 03/05/2009 | US20090060995 Dispersible sustained release pharmaceutical compositions |
| 03/05/2009 | US20090060994 Controlled release azithromycin solid dosages forms |
| 03/05/2009 | US20090060993 Solid pharmaceutical composition for enhanced delivery of coenzyme q-10 and ubiquinones |
| 03/05/2009 | US20090060992 Preparation of magneto-vesicles with DOPE/DDAB layers |
| 03/05/2009 | US20090060991 Glutathione based delivery system |
| 03/05/2009 | US20090060990 Nsaid formulations, based on highly adaptable aggregates, for improved transport through barriers and topical drug delivery |
| 03/05/2009 | US20090060989 Nsaid formulations, based on highly adaptable aggregates, for improved transport through barriers and topical drug delivery |
| 03/05/2009 | US20090060988 Nell-1 enhanced bone mineralization |
| 03/05/2009 | US20090060987 Devices, systems and methods for improving memory and/or cognitive function through brain delivery of sirna |
| 03/05/2009 | US20090060986 Transdermal delivery systems |
| 03/05/2009 | US20090060983 Method And Composition For Making An Orally Disintegrating Dosage Form |
| 03/05/2009 | US20090060982 Methods and devices for the sustained release of multiple drugs |
| 03/05/2009 | US20090060981 Contact lens based bioactive agent delivery system |
| 03/05/2009 | US20090060980 Glycan binding proteins as therapeutic targets for retinal disorders and treatment methods based thereon |
| 03/05/2009 | US20090060978 Resorbable barrier micro-membranes for attenuation of scar tissue during healing |
| 03/05/2009 | US20090060975 Containment system for delivery of biological products and method of surgery |
| 03/05/2009 | US20090060969 Porous biodegradable polymeric materials for cell transplantation |
| 03/05/2009 | US20090060968 Inhibitors of phosphatases |
| 03/05/2009 | US20090060962 Cosmetic use of bifidobacterium species lysate for the treatment of dryness |
| 03/05/2009 | US20090060956 Agent for reducing the useable calorie content of food and for therapeutic reduction of weight, in particular for use in the case of adiposity (obesity) |
| 03/05/2009 | US20090060955 Drug delivery vehicle that mimics viral properties |
| 03/05/2009 | US20090060944 Enhancer Of The Effect Of Adrenocorticoid,Comprising Gum Arabic |
| 03/05/2009 | US20090060941 Methods for the treatment of diabetes, the reduction of body fat, improvement of insulin sensitivity, reduction of hyperglycemia, and reduction of hypercholesterolemia with chromium complexes, conjugated fatty acids, and/or conjugated fatty alcohols |
| 03/05/2009 | US20090060937 Immunostimulatory oligonucleotides and uses thereof |
| 03/05/2009 | US20090060865 Mammalian receptor proteins; related reagents and methods |
| 03/05/2009 | US20090060848 Pharmaceutical composition which reduces or eliminates drug abuse potential |
| 03/05/2009 | US20090060846 nanoparticle having a core comprising a magnetic material and surface to which are covalently coupled a plurality of silane moieties |
| 03/05/2009 | US20090060840 Lanthanide Nanoparticle Conjugates and Uses Thereof |
| 03/05/2009 | DE102007041588A1 Medicament, useful for controlled, continuous or sudden release of medicinal substances in the medicament, comprises harmless, alcoholic fermentation enabled yeast, carbohydrates and water in a separate compartment |
| 03/05/2009 | DE102007041491A1 Kosmetische Pflegecreme Cosmetic cream |
| 03/05/2009 | DE102007041028A1 Verwendung estermodifizierter Organopolysiloxane zur Herstellung kosmetischer oder pharmazeutischer Kompositionen Use ester-modified organopolysiloxanes for the preparation of cosmetic or pharmaceutical compositions |
| 03/05/2009 | DE102007040615A1 Osmolyte zur Behandlung von allergisch oder viral bedingten Atemwegserkrankungen Osmolytes for treating allergic or viral respiratory diseases |
| 03/05/2009 | CA2709546A1 Surgical hydrogel |
| 03/05/2009 | CA2698103A1 Solid-state protein formulation |
| 03/05/2009 | CA2697943A1 Local topical administration formulations containing fipronil |
| 03/05/2009 | CA2697893A1 Carrier-free orodispersible and/or dispersible solid composition with noticeable effect and method for preparing same |
| 03/05/2009 | CA2697862A1 Supramacromolecular polymer complexes providing controlled nitric oxide release for healing wounds |
| 03/05/2009 | CA2697837A1 Synthesis of oseltamivir containing phosphonate congeners with anti-influenza activity |
| 03/05/2009 | CA2697825A1 Non-aqueous pharmaceutical compositions |
| 03/05/2009 | CA2697376A1 Liquid formulation of g-csf |
| 03/05/2009 | CA2696870A1 Pharmaceutical formulation for extended release |
| 03/05/2009 | CA2696622A1 Compositions for the treatment of neoplastic diseases |
| 03/05/2009 | CA2693078A1 Aerosols for sinunasal drug delivery |
| 03/04/2009 | EP2030644A1 Aerosols for sinunasal drug delivery |
| 03/04/2009 | EP2030642A1 Gelatinous protein foodstuff and process for its preparation |
| 03/04/2009 | EP2030634A1 Medicament for and method of treatment of prostate cancer |
| 03/04/2009 | EP2030632A1 A carrier particle for use in bio-applications |
| 03/04/2009 | EP2030613A1 Preparation of compositions with essentially noncrystalline embedded macrolide antibiotics |
| 03/04/2009 | EP2030612A1 Pharmaceutical composition for treating burns (variants) and a method for the production thereof (variants) |
| 03/04/2009 | EP2030611A1 Injectable multimodal polymer depot compositions and uses thereof |
| 03/04/2009 | EP2030610A1 Non-aqueous pharmaceutical compositions |
| 03/04/2009 | EP2029162A1 Composition for controlling snoring, in the form of a nasal spray |
| 03/04/2009 | EP2029146A2 Methods to administer solid dosage forms of ethinyl estradiol and prodrugs thereof with improved bioavailabilty |
| 03/04/2009 | EP2029134A1 Stabilized pharmaceutical compositions comprising fesoterodine |
| 03/04/2009 | EP2029133A1 Compositions comprising at least one naphthoic acid derivative and at least one film-forming agent, methods for preparing same, and uses thereof |
| 03/04/2009 | EP2029122A2 Autodestructive transdermal therapeutic system |
| 03/04/2009 | EP2029121A1 Transdermal therapeutic system comprising active ingredient particles and having increased active ingredient flux |
| 03/04/2009 | EP2029120A2 Nanoparticles containing three various ligands for providing immune responses against infectious agents |
| 03/04/2009 | EP2029119A2 Functionalized solid polymer nanoparticles for diagnostic and therapeutic applications |
| 03/04/2009 | EP2029118A2 Oxcarbazepine pharmaceutical formulation and its method of preparation, wherein oxcarbazepine has a broad and multi-modal particle size distribution |
| 03/04/2009 | EP2029117A2 Rapid dissolution of combination products |
| 03/04/2009 | EP2029116A1 Segmented pharmaceutical dosage forms |
| 03/04/2009 | EP2029115A2 Disposable infusion device with linear peristaltic pump |
| 03/04/2009 | EP2029114A2 Pharmaceutical compositions for sustained release of phenyephrine |
| 03/04/2009 | EP2029113A2 Process for making multiparticulates using a roller compactor |
| 03/04/2009 | EP2029112A2 Pharmaceutical composition comprising hydrochlorothiazide and telmisartan |
| 03/04/2009 | EP2029111A2 Microparticles and methods for production thereof |
| 03/04/2009 | EP2029110A1 Process for preparing spray dried formulations of tmc125 |
| 03/04/2009 | EP2029109A1 Method for preparing polymeric matrices by radiation in the presence of sensitive pharmaceutical compounds |
| 03/04/2009 | EP2029107A2 Utilization of vinyl acetate sulfonate copolymers as solubilizers for compounds with low solubility in water |